Clinical Trials on PDD

Total 575 results

Tel-Aviv Sourasky Medical Center

Unknown

Neurofeedback Treatment of Affective Instability in Premenstrual Dysphoric Disorder(PMDD)

Depression | Premenstrual Dysphoric Disorder (PMDD)

Israel
Shanghai Zhongshan Hospital
RenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine and other collaborators

Recruiting

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Intrahepatic Cholangiocarcinoma | Lenvatinib | PD1 Antibody | Gemox Chemotherapy

China
Zhongda Hospital

Completed

Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease

PAD

China
Changping Laboratory

Not yet recruiting

pBFS Guided rTMS Over Different Targets for Treatment-Resistant Depression

Major Depressive Disorder | Treatment Resistant Depression | MDD
Changping Laboratory

Recruiting

rTMS Therapy for Treatment-Resistant Depression With Different Targets Guided by pBFS

Major Depressive Disorder | Treatment Resistant Depression | MDD

China
Takeda
Takeda Development Center Americas, Inc.

Not yet recruiting

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases (PID)
Second Affiliated Hospital, School of Medicine,...
First People's Hospital of Hangzhou

Recruiting

Comparison of PD1+T Cell Expression in Peripheral Blood for Cardiac Function Prognosis in Patients With Acute MI

Acute Myocardial Infarction | PD1

China
Northwell Health

Not yet recruiting

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies (3D-US)

Vascular Diseases | Wounds | PAD - Peripheral Arterial Disease
Baxalta now part of Shire

Completed

A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Primary Immunodeficiency Diseases (PID)

Japan
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

Primary Immunodeficiency Diseases (PID)

Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
Shire

Completed

Retrospective, Observational Chart Review Study Conducted in Poland to Document the Management and Clinical Outcome of CUVITRU and HYQVIA in Pediatric Participants (< 18 Years) With Primary Immunodeficiency (PID) (IG-TATRY)

Primary Immunodeficiencies (PID)

Poland
Baxalta now part of Shire

Completed

Phase 2/3 Study of IGSC, 20% in PIDD

Primary Immunodeficiency Diseases (PID)

United States, Canada
Baxalta now part of Shire

Completed

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
National Institute of Mental Health (NIMH)

Terminated

Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

Depression | Premenstrual Dysphoric Disorder | Premenstrual Syndrome | PMS | PMDD

United States
Baodong Qin

Unknown

Effect of Chemotherapy on PD-L1 in NSCLC

Chemotherapy | Immunotherapy | PD-L1

China
Federal Research Institute of Pediatric Hematology...

Recruiting

Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies

Primary Immunodeficiency Diseases (PID)

Russian Federation
Armed Forces Post Graduate Medical Institute (AFPGMI)...

Recruiting

Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease

PAD - Peripheral Arterial Disease | Combined Anticoagulation and Antithrombotic Therapy

Pakistan
Baxalta now part of Shire

Completed

Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects

Primary Immunodeficiency Diseases (PID)

United States
Baxalta now part of Shire

Completed

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Primary Immunodeficiency Diseases (PID)

United States
Schoenhaus, Jodi, DPM

Unknown

Pressure Offloading Injectible System With the Use of Juvederm Voluma in the Foot (POIS)

Metatarsalgia | Fat Pad Syndrome | Corns | Hyperkeratotic Callus

United States
Charite University, Berlin, Germany
European Union

Terminated

Biomarker Development for Postoperative Cognitive Impairment in the Elderly (BioCog) (BioCog)

Postoperative Delirium (POD) | Postoperative Cognitive Deficit (POCD)

Germany, Netherlands
Bayer

Completed

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Premenstrual Dysphoric Disorder ( PMDD)

China
University of Florida

Completed

CODY (Co-design for You): An Immersive Technology Tool for Experiencing and Assessing Home Alterations

Parkinson Disease (PD)

United States
Actinogen Medical
AXIOM Real Time Metrics

Active, not recruiting

Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)

Cognitive Impairment | Major Depressive Disorder | MDD

Australia, United Kingdom
AstraZeneca
CPC Clinical Research

Terminated

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR (TI-PAD EVR)

Peripheral Artery Disease (PAD)

United States
Beijing Hospital

Completed

A Study Evaluating the Bioavailability of Oral Insulin (N11005)

PK, PD, and Safety

China
Sun Yat-sen University

Recruiting

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL

Pediatric Cancer | Anaplastic Lymphoma | MDD | MRD | Lymphoma, Nonhodgkin

China
Murdoch Childrens Research Institute
Monash Medical Centre

Terminated

HPV Vaccination in Special Risk Groups: 5 Year Follow-up

PRD (Paediatric Rheumatological Disease) | IBD (Inflammatory Bowel Disease)

Australia
Takeda

Recruiting

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

Primary Immunodeficiency Diseases (PID)

United States
Takeda
Takeda Development Center Americas, Inc.

Recruiting

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Primary Immunodeficiency Diseases (PID)

United States
Takeda

Completed

A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)

Primary Immunodeficiency Diseases (PID)

Japan
Baxalta now part of Shire

Completed

Immune Globulin Subcutaenous (Human), 20%

Primary Immunodeficiency Diseases (PID)

Germany, Austria, Hungary, Sweden, United Kingdom
CSL Behring

Completed

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

Primary Immunodeficiency (PID)

Poland, Germany, France, Romania, Spain, Sweden, Switzerland, United Kingdom
Southeast University, China

Unknown

Immunoregulatory Therapy for 2019-nCoV

2019 nCoV, PD-1
Aalborg University Hospital
Aalborg University; Sygekassernes Helsefond; Svend Andersens Foundation; Peacs; Karl...

Completed

Risk of Pacing-induced Cardiomyopathy

Atrioventricular Block | Pacemaker DDD | Pacing-Induced Cardiomyopathy

Denmark
Centro Hospitalar do Porto
University of Trás-os-Montes and Alto Douro; Foundation for Science and Technology... and other collaborators

Recruiting

Home-based Exercise Therapy for Patients With PAD (WalkingPAD)

Intermittent Claudication | Peripheral Arterial Disease (PAD)

Portugal
Goztepe Prof Dr Suleyman Yalcın City Hospital

Completed

Video Training to Reduce Insulin Administration Errors

Diabetes Mellitus, Type 2 | Educational Problems | Injection Site | Insulin Injection Pad | Insulin Implementation Errors

Turkey
Zhejiang Zylox Medical Device Co., Ltd.

Recruiting

Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia (UltraFuture I)

Peripheral Arterial Disease (PAD)

China
National Cardiovascular Center Harapan Kita Hospital...

Completed

Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure

Echocardiography | PDA

Indonesia
Steward St. Elizabeth's Medical Center of Boston...

Recruiting

Left Bundle Branch Area Mapping for Conduction System Pacing

Left Bundle-Branch Block | Pacemaker DDD

United States
Benvenue Medical, Inc.

Unknown

Luna Interbody System for Fusion Trial (LIFT)

Lower Back Pain | Degenerative Disc Disease (DDD)

Germany, Belgium
CSL Limited

Completed

Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

Primary Immune Deficiency (PID)

Australia
Jeffrey A. Gusenoff, MD

Completed

Validation of a Novel Foot Offloading Device (PopSole2)

Heel Pain Syndrome | Plantar Fasciitis, Chronic | Fat Pad Syndrome

United States
Apeptico Forschung und Entwicklung GmbH

Completed

Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation

PGD Primary Graft Dysfunction

Austria
Maastricht University Medical Center

Not yet recruiting

Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial (PACE-AF)

Atrial Fibrillation | Pacemaker DDD | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Permanent Atrial Fibrillation
University of Texas at Austin

Not yet recruiting

Psilocybin rTMS for Treatment Resistant Depression (PSILOBSD)

Depression | Major Depressive Disorder | Treatment Resistant Depression | MDD | Recurrent Depression

United States
Medical University of Vienna

Completed

Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders (MAN-BIOPSY)

Major Depressive Disorder (MDD) | Anxiety Disorder

Austria
Chang Gung University

Completed

Gait Initiation Difficulty and Anticipatory Postural Adjustment (APA) Impairment in People With PD - Evaluation and Training

Parkinson Disease(PD)

Taiwan
Consorzio Oncotech

Completed

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study (ARIES)

Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer

Italy

Clinical Trials on PDD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations